SEC Form D · filed April 19, 2021
Emerald Health Pharmaceuticals Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
James L. Heppell · San Diego, CADirectorAlain S. Rolland · San Diego, CAExecLisa S. Sanford · San Diego, CAExecEduardo S. Munoz · San Diego, CAExecJames S. Demesa · San Diego, CAExec · DirectorJoachim S. Schupp · San Diego, CAExecGaetano A. Morello · San Diego, CADirectorPunit S. Dhillon · San Diego, CADirectorAndrew Davidson · SASKATOON, Saskatchewan, CanadaExec · DirectorMichael Mccoy · Nashville, TNDirectorDavid S. Blumberg · Southlake, TXExecTom Macneill · SASKATOON, Saskatchewan, CanadaDirectorPierre-Yves Larose · SASKATOON, Saskatchewan, CanadaExecStephen M. Ewen · Cleveland, OHDirectorDenis Clement · SASKATOON, Saskatchewan, CanadaExecSylvain Laberge · SASKATOON, Saskatchewan, CanadaExecStephen Lebowitz · Larchmont, NYExec · DirectorLeighton Cusack · Brooklyn, NYExecRichard Prince, Phd · Summit, NJExecTravis Gering · Summit, NJDirectorJoel Friedman, Md, Phd · Summit, NJExecGraeme Silbert · Summit, NJDirectorWilliam R. Wilson · Toronto, Ontario, CanadaExecMichael K. Cotant · Bloomfield Hills, MIDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗